Does TRIPTORELIN Cause Product dose omission issue? 178 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 178 reports of Product dose omission issue have been filed in association with TRIPTORELIN (TRIPTODUR). This represents 3.3% of all adverse event reports for TRIPTORELIN.
178
Reports of Product dose omission issue with TRIPTORELIN
3.3%
of all TRIPTORELIN reports
6
Deaths
27
Hospitalizations
How Dangerous Is Product dose omission issue From TRIPTORELIN?
Of the 178 reports, 6 (3.4%) resulted in death, 27 (15.2%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIPTORELIN. However, 178 reports have been filed with the FAERS database.
What Other Side Effects Does TRIPTORELIN Cause?
Off label use (545)
Death (362)
Ovarian hyperstimulation syndrome (356)
Needle issue (242)
Disease progression (203)
Drug ineffective (175)
Weight increased (167)
Hot flush (153)
Headache (145)
Injection site pain (138)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which TRIPTORELIN Alternatives Have Lower Product dose omission issue Risk?
TRIPTORELIN vs TRISODIUM
TRIPTORELIN vs TROFINETIDE
TRIPTORELIN vs TROFOSFAMIDE
TRIPTORELIN vs TROPATEPINE
TRIPTORELIN vs TROPICAMIDE